University of Kansas Medical Center
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Kansas Medical Center sits in the top decile of US sponsors by registered trial count (#88 of 15,742 sponsors by registered trial count).
University of Kansas Medical Center: 408 sponsored US clinical trials, 93 recruiting.
University of Kansas Medical Center sponsors 408 registered US clinical trials on ClinicalTrials.gov, 93 of them currently recruiting, and 252 completed. 28 of these trials are in Phase 3-4 (later-stage) and 85 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Smoking Cessation, with 9 trials.
Top-decile sponsor footprint
University of Kansas Medical Center ranks in the top decile of sponsors by registered trial count (#88 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
252 of 275 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
408 total, page 3 of 9
Rural Engagement in TelemedTeam for Options in Obesity Treatment Solutions
NCT05710510
Tg01 Vaccine / Qs-21 Stimulon™ With Or Without Balstilimab As Maintenance Therapy Following Adjuvant Chemotherapy In Patients With Resected Pancreatic Cancer
NCT05638698
Itraconazole to Prevent Recurrent Barrett's Esophagus
NCT05609253
Developing Hyperpolarized 129Xe MRI Biomarkers for Evaluation of Pulmonary Arterial Hypertension
NCT05339386
Partial Sleep Restriction in Chronic Low Back Pain: A Feasibility Study
NCT07008924
Phase III Trial of Sirolimus in IBM
NCT04789070
MRI for Screening and Monitoring Scleroderma ILD
NCT05204355
Alpelisib And Sacituzumab Govitecan For Treatment Of Breast Cancer
NCT05143229
The Purpose of This Trial is to Determine if Regorafenib Plus Durvalumab (MEDI4736) is Safe and Effective in Treatment of Chemo Refractory Advanced Biliary Tract Cancers
NCT04781192
Effect of Losartan in Cystic Fibrosis (CF)-NIH Grant #133240
NCT03435939
Improving Pain Management Via Spinal Cord Stimulation and Blood Pressure Reduction
NCT04676399
Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens
NCT04821141
Remote Monitoring and Virtual Collaborative Care For Hypertension Control to Prevent Cognitive Decline Phase II
NCT05138601
Combined Exercise Trial
NCT04848038
Pharmacogenomic Modulators of Impaired Exercise Adaptation in Statin Users
NCT04636138
Changing Talk Online Training (CHATO) National Trial
NCT04610944
Hyperpolarized 129Xe MRI of Survivors of COVID-19
NCT04659707
Epidural Spinal Cord Stimulation for Hypertension in Patients With Neuropathic Pain
NCT04598035
COVID-19 Biorepository
NCT04568148
Intravenous (IV) Vitamin C With Chemotherapy for Cisplatin Ineligible Bladder Cancer Patients
NCT04046094
Sexual Health Empowerment for Women's Health
NCT03984695
Neoadjuvant Phase II Study of Pembrolizumab And Carboplatin Plus Docetaxel in Triple Negative Breast Cancer
NCT03639948
Perioperative mFOLFOX Plus Pembrolizumab in Gastroesophageal Junction (GEJ) and Stomach Adenocarcinoma
NCT03488667
Ultra-hypofractionated Radiation in Prostate Cancer
NCT03486821
Omission of Radiation in Patients With Her-2 Positive Breast Cancer
NCT03460067
Hypofractionated Radiation Therapy for Patients With Breast Cancer Receiving Regional Nodal Irradiation
NCT02958774
Contingency Management to Promote Smoking Cessation: A Pilot Randomized Clinical Trial
NCT07685899
Is Nipple Stimulation Effective for Inducing Labor and Acceptable to Patients, Nurses, and Providers?
NCT07588529
Ketogenic Diet to Reduce Osteoarthritis Pain in MCI
NCT07417891
Low-Fidelity Driving Simulator Training in Parkinson's Disease.
NCT07463755
Walking and tSCS in Non-ambulatory Stroke Survivors
NCT07226518
Remotely Monitored, Mobile Health-supported, High Intensity Interval Training Before Hematopoietic Stem Cell Transplant
NCT06953648
Patient Factors Associated With Fragmentation of Copper Intrauterine Device (IUD) Requiring Hysteroscopic Removal
NCT07351084
Measuring Reliability of Spine Mobilization in Low Back Pain
NCT07582705
Brain Health in Midlife
NCT06640842
Decreasing Alzheimer's Risk Through oNline Choreographed Exercise - Down Syndrome
NCT06537648
Singing Intervention for Chronic Obstructive Pulmonary Disease (COPD)
NCT07563283
Strength Training and Muscle Lipids
NCT06480747
Cooling Agent Pilot Among Adult Menthol Smokers
NCT06477601
DPP Feasibility Study of Breastfeeding - eMOMS 2.0
NCT06372860
Testing Swim Instruction for Autistic Children
NCT06216613
Nutricity: An mHealth Nutrition Intervention to Improve Diet Quality Among Latino Children
NCT06266468
Sleep Health Enhancement in Midlife Adults
NCT06311500
ECoLoGiC Speech Therapy for Everyday Communication in Aphasia
NCT06132464
Lifileucel With Reduced Dose Fludarabine/Cyclophosphamide Lymphodepletion and Interleukin-2 for the Treatment of Patients With Unresectable or Metastatic Melanoma
NCT06151847
Multimodal Exercise Training to Reduce Frailty in People With Multiple Sclerosis
NCT06042244
Relugolix in Combination With Radiation Therapy for Treating Patients With High Risk Prostate Cancer
NCT06129851
Effects of Beet Juice and Diet in Female Rowers
NCT06045845
Sleep Health Enhancement in Older Adults to Address Frailty
NCT05968820
Investigating the Relationship Between Triglycerides and Fetal Overgrowth in Gestational Diabetes
NCT06067685
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 40 |
| Phase 2 | 45 |
| Phase 3 | 9 |
| Phase 4 | 19 |
Therapeutic Areas
What is open in the University of Kansas Medical Center pipeline
93 recruiting of 408 indexed (23% open); 252 completed (62%).
Phase mix: 28 late (III/IV) vs 85 early (I/II) (early-phase heavy).
Top condition: Smoking Cessation (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Kansas Medical Center: open-pipeline peers nationwide
Peers matched on 408 registered trials and 23% open enrollment, not the therapeutic-area sidebar.
University of Kansas Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 408 trials (± recruiting share)
- Takeda · 408 trials · 12% recruiting
- Case Comprehensive Cancer Center · 407 trials · 14% recruiting
- University of Nebraska · 407 trials · 13% recruiting
- St. Jude Children's Research Hospital · 410 trials · 22% recruiting
Sponsors near 23% open enrollment (± trial volume)
- Veterans Medical Research Foundation · 23% recruiting · 35 trials
- University of Delaware · 23% recruiting · 106 trials
- University of Texas at Austin · 23% recruiting · 257 trials
- Ohio State University Comprehensive Cancer Center · 23% recruiting · 341 trials
Related
What to do with this University of Kansas Medical Center page
408 registered trials is a research-attention snapshot, not an endorsement of University of Kansas Medical Center or any single study.
- 93 of University of Kansas Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Smoking Cessation is the condition University of Kansas Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Smoking Cessation trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Kansas Medical Center pipeline card: 408 registered trials from official public datasets.Report a data error.